Beyond Survival: The New Front in Cancer Care Is Preserving the Future

DENVER, CO – July 28, 2026 – For the nearly 90,000 adolescents and young adults (AYAs) diagnosed with cancer each year in the United States, the immediate battle is for survival. But a secondary, often silent crisis emerges once the fight is over: the chance to build a family. A new partnership aims to break that silence by transforming personal tragedy into a powerful force for systemic change, highlighting a crucial evolution in what it means to provide comprehensive cancer care.

The nonprofit Worth the Wait has selected M&C Communications, a public relations firm, to lead its new Oncofertility Speakers Bureau. The initiative will train AYA cancer survivors to share their stories, raising awareness about a critical gap in care. The move comes in response to stark data, including a 2024 JAMA Network Open study which found that nearly half of reproductive-age patients with early-onset cancer did not recall ever discussing fertility preservation options with their medical team before treatment began. This partnership isn't just about media training; it's about architecting a new advocacy model to ensure the next generation of cancer patients doesn't have its future parenthood options erased by a conversation that never happened.

The Silent Crisis in Survivorship

The long-term consequences of a cancer diagnosis for young adults extend far beyond the physical scars of treatment. For many, the chemotherapy, radiation, and surgeries necessary to save their lives can permanently damage their reproductive systems. Research indicates that up to 80% of AYA patients experience some level of reduced fertility following treatment. This medical reality clashes with a powerful human desire; studies show that an estimated 70-75% of these same survivors express an interest in one day having children.

This creates a devastating gap between aspiration and possibility, a gap often widened by a failure to communicate. Despite guidelines from major medical bodies, the oncofertility conversation is frequently missed in the whirlwind of a new diagnosis. The impact is profound. Survivors are left to navigate not only the emotional trauma of their cancer journey but also the potential grief of involuntary childlessness. This is compounded by immense financial pressure. Cancer-related financial toxicity is a well-documented crisis, and the cost of fertility preservation—with a single egg-freezing cycle often exceeding $10,000, not including annual storage fees—places it out of reach for many young adults already facing mountains of medical debt.

"Patients may not know to even ask about the treatment’s impact on their fertility," said Diane Mulligan, Founder and President of M&C Communications. The Oncofertility Speakers Bureau is designed to arm future patients with the one thing that can change this dynamic: knowledge born from lived experience. By hearing from those who have walked this path, the initiative aims to empower patients to become their own best advocates at a moment when they are at their most vulnerable.

Architecting Advocacy: A New Model for Change

Turning deeply personal narratives into instruments of public education and policy change requires a deliberate strategy. This is where the partnership between a survivor-led nonprofit and a strategic communications firm becomes a compelling model for social impact. Worth the Wait, co-founded by Executive Director Megan Scherer and her husband Mike, a cancer survivor, has spent five years providing financial aid and resources to AYA survivors navigating the complex path to parenthood. The organization was born from direct experience with the system's shortcomings.

The new Speakers Bureau formalizes their advocacy work, creating a trained cohort of voices to engage with media, medical professionals, and policymakers. M&C Communications brings its "Insider Media Relations™" approach, a methodology developed by former journalists to hone storytelling skills, build media relationships, and ensure a message is delivered with precision and impact. It’s a shift from simple awareness to strategic influence.

“We help advocates turn their deeply personal experiences into inspiring stories that educate the public about preserving their fertility options when they are first diagnosed,” Mulligan explained. The goal is to prepare survivors not just to tell their story, but to deploy it where it can make the most difference—prompting life-changing discussions in exam rooms across the country.

For Worth the Wait, this professional training is essential for navigating the sensitive and complex nature of the issue. “Too many young adults face cancer treatment without fully understanding how it may affect their ability to build a family in the future," said Megan Scherer. "Partnering with M&C Communications helps us prepare advocates to share those stories with the clarity, confidence, and compassion this issue deserves.”

From Bedside to Policy: Shifting the System

The ultimate goal of this advocacy extends beyond individual conversations and into the very structure of healthcare delivery and policy. Professional organizations like the American Society of Clinical Oncology (ASCO) and the American Society for Reproductive Medicine (ASRM) have long-established guidelines recommending that providers discuss potential infertility and preservation options with patients before treatment. ASCO’s 2025 guidelines reinforce this, recommending that discussions and referrals be offered not just at diagnosis but annually throughout survivorship.

However, implementation at the bedside remains inconsistent. Oncologists often face a difficult balancing act, concerned about overwhelming a distressed patient or potentially delaying life-saving treatment. Yet, evidence suggests these fears may be overcome with better systems. One quality improvement project at a major cancer center demonstrated that strategic planning and automated alerts could significantly increase fertility preservation counseling without causing treatment delays. This suggests the problem is not one of intention, but of process—a systemic flaw that patient advocacy can help expose and correct.

The policy landscape is a similar patchwork. In a significant step forward, 21 states and the District of Columbia have enacted laws mandating some level of insurance coverage for fertility preservation due to medical necessity. But a major loophole persists: these state mandates do not apply to the majority of the American workforce covered by self-insured employer health plans, which are regulated federally. This creates deep inequities in access. Advocacy groups are now pushing for a federal mandate to close this gap, and the powerful, personal stories cultivated by the Speakers Bureau will be a key tool in that legislative fight. By humanizing the consequences of policy gaps, these survivors provide the "why" that can spur lawmakers to action, building a more resilient and comprehensive system of care that truly supports life after cancer.